Michael Khan

Michael Khan

Chief Executive Officer at
Argonaute RNA Ltd.
Commercial Services
Consumer Services

Profile

Michael Khan is currently the Chief Executive Officer at Argonaute RNA Ltd. He is also a Member at Diabetes UK and HEART UK.
Previously, he served as the Executive Director & Chief Medical Officer at Silence Therapeutics Plc from 2013 to 2016.
He also held the position of Head-Molecular Medicine & Associate Professor at the University of Warwick.
Dr. Khan holds a doctorate degree from University College London.

Michael Khan active positions

CompaniesPositionStart
HEART UK
Corporate Officer/Principal -
Diabetes UK
Corporate Officer/Principal -
Chief Executive Officer 01/01/2021

Former positions of Michael Khan

CompaniesPositionEnd
SILENCE THERAPEUTICS PLC Chief Tech/Sci/R&D Officer 17/06/2016
Corporate Officer/Principal -
See the detail of Michael Khan's experience

Training of Michael Khan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

21

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Commercial Services

Consumer Services

Consumer Services

Diabetes UK

HEART UK

Commercial Services

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!